FIELD: organic chemistry, chemical technology, medicine.
SUBSTANCE: invention relates to acyclic nucleoside phosphonate derivatives of the formula (1): wherein means a simple or double bond; R1 means hydrogen atom; R2 and R3 mean hydrogen atom or (C1-C7)-alkyl; R7 and R8 mean hydrogen atom or (C1-C4)-alkyl; R4 and R5 mean hydrogen atom or (C1-C4)-alkyl possibly substituted with one or more halogen atoms, or -(CH2)m-OC(=O)-R6 wherein m means a whole number from 1 to 5; R6 means (C1-C7)-alkyl or 3-6-membered heterocycle comprising 1 or 2 heteroatoms taken among the group consisting of nitrogen (N) and oxygen (O) atoms; Y means -O-, -CH(Z)-, =C(Z)-, -N(Z)- wherein Z means hydrogen atom, hydroxy-group or halogen atom, or (C1-C7)-alkyl; Q (see the claim invention); its pharmaceutically acceptable salts or stereoisomers. Also, invention proposes methods for preparing compounds of the formula (1) and their using in treatment of hepatitis B or preparing a medicinal agent designated for this aim.
EFFECT: improved preparing method, valuable medicinal properties of compounds and agent.
16 cl, 10 tbl, 87 ex
Title | Year | Author | Number |
---|---|---|---|
NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | 2019 |
|
RU2809547C2 |
NOVEL DERIVATIVE OF PURINYLPYRIDINYLAMINO-2,4-DIFLUOROPHENYLSULPHONAMIDE, ITS PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH HAS INHIBITION ACTIVITY WITH RESPECT TO RAF-KINASE, CONTAINING CLAIMED COMPOUND AS ACTIVE INGREDIENT | 2011 |
|
RU2550038C2 |
THIENO[3,2-d]PYRIMIDINE DERIVATIVES, POSSESSING INHIBITING ACTION WITH RESPECT TO PROTEINKINASE | 2011 |
|
RU2524210C2 |
2-PYRIDYL-SUBSTITUTED IMIDAZOLS AS ALK5 AND/OR ALK4 RECEPTOR INHIBITORS | 2004 |
|
RU2348626C2 |
DERIVATIVES OF PYRROLOPYRIMIDINE, METHOD FOR PREPARING AND THEIR USING | 2001 |
|
RU2263676C2 |
NOVEL BENZAMIDE DERIVATIVES | 2011 |
|
RU2536688C2 |
PEPTIDE NUCLEIC ACID DERIVATIVES WITH GOOD CELL PENETRATION AND STRONG AFFINITY FOR NUCLEIC ACID | 2009 |
|
RU2564032C2 |
7-SUBSTITUTED SULFONIMIDOYLPURINONES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTION | 2017 |
|
RU2751349C2 |
COMBINATIVE MEDICINAL AGENT | 2003 |
|
RU2328280C2 |
VAR2CSA-DRUG CONJUGATES | 2014 |
|
RU2714933C2 |
Authors
Dates
2005-12-20—Published
2002-01-18—Filed